K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 697.00
+17.00 (2.50%)
Oct 26, 2026, 3:30 PM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 8.1 billion as of October 26, 2026. It is the 29,996th most valuable company in the world and the 2,696th biggest in Japan. Its market cap has increased by 7.40% in one year.
Market Cap
8.10B
Enterprise Value
7.37B
Revenue
n/a
Global Rank
Country Rank
#2,696 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 8.10B, a decrease of -25.99%. That is a compound annual growth rate of -9.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 8.10B | 5.77% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 9.34B |
| StemRIM | 9.28B |
| Carna Biosciences | 8.18B |
| Kidswell Bio | 7.54B |
| CellSeed | 7.46B |
| J-Pharma | 7.35B |
| OncoTherapy Science | 7.35B |
| Nano Holdings | 7.17B |